Moderna (MRNA) has had the highest return since January 1, 2026 by a large-cap US stock, returning 654.3%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 654.27% |
Sandisk (SNDK) | 547.36% |
Immunitybio (IBRX) | 420.3% |
Twist Bioscience (TWST) | 403.56% |
10X Genomics (TXG) | 394.48% |
Dell Technologies (DELL) | 360.61% |
Micron Technology (MU) | 248.86% |
Corcept Therapeutics (CORT) | 238.9% |
Marvell Technology (MRVL) | 217.9% |
Bloom Energy (BE) | 209.71% |
Hewlett Packard Enterprise (HPE) | 206.17% |
Frontline (FRO) | 203.96% |
United Microelectronics (UMC) | 197.63% |
Lumentum (LITE) | 190.83% |
Marathon Petroleum (MPC) | 182.66% |
ASE Industrial Holding Co Ltd ADR (ASX) | 181.33% |
Seagate Technology (STX) | 178.6% |
Advanced Micro Devices (AMD) | 177.8% |
Intel (INTC) | 177.2% |
DigitalOcean (DOCN) | 177.18% |
HF Sinclair (DINO) | 169.87% |
Valero Energy (VLO) | 169.63% |
Okta (OKTA) | 166.36% |
Nebius (NBIS) | 154.15% |
Viavi Solutions (VIAV) | 151.86% |
Large-cap stocks are treated as having a market cap of $10B+.